Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy

被引：6

作者：

Nott, L. ^{[1
]}

Price, T. J. ^{[1
]}

Pittman, K. ^{[1
]}

Patterson, K. ^{[1
]}

Young, R. ^{[2
]}

Fletcher, J. ^{[3
]}

机构：

[1] Queen Elizabeth Hosp, Dept Oncol, Adelaide, SA, Australia

[2] Wakefield Hosp, Intens Care Unit, Adelaide, SA, Australia

[3] Women & Childrens Hosp, Dept Biochem, Adelaide, SA, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2008年 / 38卷 / 10期

关键词：

hyperammonaemic encephalopathy; rituximab; chemotherapy;

D O I：

10.1111/j.1445-5994.2008.01772.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hyperammonaemic encephalopathy has been infrequently reported after both standard and high-dose chemotherapy for solid and haematological malignancies. It is important to consider this diagnosis for patients with unexplained behaviour changes or encephalopathy and this case report emphasizes this condition and the importance of early diagnosis and is the first reported in association with rituximab-containing chemotherapy.

引用

页码：800 / 803

页数：4

共 16 条

[1] Alternative pathway therapy for urea cycle disorders: Twenty years later [J].

Batshaw, ML ;

MacArthur, RB ;

Tuchman, M .

JOURNAL OF PEDIATRICS, 2001, 138 (01) :S46-S54

[2] Hyperammonemic encephalopathy [J].

Brusilow, SW .

MEDICINE, 2002, 81 (03) :240-249

[3]

Davies SM, 1996, BONE MARROW TRANSPL, V17, P1119

[4]

ESPINOS J, 1988, AM J MED, V85, P662

[5] Risk of transient hyperammonemic encephalopathy in cancer patients who received continuous infusion of 5-fluorouracil with the complication of dehydration and infection [J].

Liaw, CC ;

Wang, HM ;

Wang, CH ;

Yang, TS ;

Chen, JS ;

Chang, HK ;

Lin, YC ;

Liaw, SJ ;

Yeh, CT .

ANTI-CANCER DRUGS, 1999, 10 (03) :275-281

[6] Fatal hyperammonemia after orthotopic lung transplantation [J].

Lichtenstein, GR ;

Yang, YX ;

Nunes, FA ;

Lewis, JD ;

Tuchman, M ;

Tino, G ;

Kaiser, LR ;

Palevsky, HI ;

Kotloff, RM ;

Furth, EE ;

Bavaria, JE ;

Stecker, MM ;

Kaplan, P ;

Berry, GT .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (04) :283-287

[7]

MATSUZAKI H, 1990, ACTA HAEMATOL-BASEL, V84, P130

[8]

MATSUZAKI H, 1995, INT J HEMATOL, V61, P131

[9]

MITCHELL RB, 1988, AM J MED, V85, P662

[10] Hyperammonemia encephalopathy: An important cause of neurological deterioration following chemotherapy [J].

Nott, Louise ;

Price, Timothy J. ;

Pittman, Ken ;

Patterson, Kevin ;

Fletcher, Janice .

LEUKEMIA & LYMPHOMA, 2007, 48 (09) :1702-1711

← 1 2 →